» Articles » PMID: 12384440

The Src Homology 2 Domain-containing Inositol 5-phosphatase Negatively Regulates Fcgamma Receptor-mediated Phagocytosis Through Immunoreceptor Tyrosine-based Activation Motif-bearing Phagocytic Receptors

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Oct 18
PMID 12384440
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular mechanisms by which the Src homology 2 domain-containing inositol 5-phosphatase (SHIP) negatively regulates phagocytosis in macrophages are unclear. We addressed the issue using bone marrow-derived macrophages from FcgammaR- or SHIP-deficient mice. Phagocytic activities of macrophages from FcgammaRII(b)(-/-) and SHIP(-/-) mice were enhanced to a similar extent, relative to those from wild type. However, calcium influx was only marginally affected in FcgammaRII(b)(-/-), but greatly enhanced in SHIP(-/-) macrophages. Furthermore, SHIP was phosphorylated on tyrosine residues upon FcgammaR aggregation even in macrophages from FcgammaRII(b)(-/-) mice or upon clustering of a chimeric receptor containing CD8 and the immunoreceptor tyrosine-based activation motif (ITAM)-bearing gamma-chain or human-restricted FcgammaRIIa. These findings indicate that, unlike B cells, SHIP is efficiently phosphorylated in the absence of an immunoreceptor tyrosine-based inhibition motif (ITIM)-bearing receptor. We further demonstrate that SHIP directly bound to phosphorylated peptides derived from FcgammaRIIa with a high affinity, comparable to that of FcgammaRII(b). Lastly, FcgammaRIIa-mediated phagocytosis was significantly enhanced in THP-1 cells overexpressing dominant-negative form of SHIP in the absence of FcgammaRII(b). These results indicate that SHIP negatively regulates FcgammaR-mediated phagocytosis through all ITAM-containing IgG receptors using a molecular mechanism distinct from that in B cells.

Citing Articles

Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite.

Bond A, Morrissey M J Cell Sci. 2025; 138(1).

PMID: 39749603 PMC: 11828473. DOI: 10.1242/jcs.263513.


Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease.

Terzioglu G, Young-Pearse T Mol Neurodegener. 2023; 18(1):89.

PMID: 38017562 PMC: 10685641. DOI: 10.1186/s13024-023-00674-9.


INPP5D regulates inflammasome activation in human microglia.

Chou V, Pearse 2nd R, Aylward A, Ashour N, Taga M, Terzioglu G Nat Commun. 2023; 14(1):7552.

PMID: 38016942 PMC: 10684891. DOI: 10.1038/s41467-023-42819-w.


Pathological Roles of INPP5D in Alzheimer's Disease.

Chu Y, Akahori A, Takatori S, Tomita T Adv Exp Med Biol. 2023; 1423:289-301.

PMID: 37525057 DOI: 10.1007/978-3-031-31978-5_30.


An Imaging Flow Cytometry Protocol for Studying Immunoregulatory Receptor-Mediated Regulation of Phagocytosis.

Zwozdesky M, Fei C, Stafford J Methods Mol Biol. 2021; 2421:201-216.

PMID: 34870821 DOI: 10.1007/978-1-0716-1944-5_14.